|
Re: neoadjuvant study shows AI treatment may upregulate her2
since there seems to be cross talk between the ER and the her 2 receptor using a drug which irreversibly degrades the ER might possibly be more effective than just starving the ER of its ligand (estrogen)
Having no ER to cross talk with the her2 receptor may be more effective at stopping growth than having a "starved" ER talk to the her2 receptor, upregulate its pathway and give the tumor an alternative pathway to escape the ligand starvation of the ER.
|